Articles tagged with Cardiovascular Disease
A study co-authored by past presidents of The Obesity Society shows that Wegovy can reduce existing heart disease in patients with obesity. The medication, semaglutide, was found to be life-saving and can benefit all sub-groups studied.
A study of US neighborhoods found a strong association between environmental burden and higher rates of cardiovascular risk factors and diseases. Socially vulnerable neighborhoods showed the strongest associations, highlighting the need for initiatives to address poor environmental conditions and improve cardiovascular health.
Scientists at the University of Leicester have made a groundbreaking discovery about how cholesterol in our diet is absorbed into our cells. The research, published in Science, highlights the role of two proteins called Aster B and Aster C in transporting cholesterol from the intestine to the bloodstream.
A 20% reduction in major adverse cardiovascular events has been observed for patients with obesity but no history of diabetes taking semaglutide. This study marks a significant milestone, demonstrating the cardiovascular benefits of semaglutide beyond its weight loss effects.
A three-year intensive treatment strategy to lower systolic blood pressure below 120mmHg significantly reduced cardiovascular events, including heart attack, stroke, and death, compared to standard treatment. The study found that participants in the intensive group experienced fewer major vascular events and deaths over a two-year period.
The ORBITA-2 trial found that stenting improves symptoms compared to a placebo procedure, providing evidence-based treatment for stable chest pain. The study suggests updating guidelines for stable coronary artery disease and offers patients and medical teams two treatment strategies with similar benefits.
Researchers found that people with overweight or obesity who took semaglutide for over 3 years had a 20% lower risk of heart attack, stroke, or death from cardiovascular disease. The study showed significant weight loss and improved cardiovascular outcomes in adults without diabetes.
A new study suggests that a PCSK9 inhibitor given every 1-3 months may effectively lower bad cholesterol levels in people with non-genetic hypercholesterolemia. The medication, recaticimab, showed similar effectiveness and safety as other PCSK9 inhibitors when administered less frequently.
Patients with heart failure treated with dapagliflozin experienced frequent initial estimated glomerular filtration rate declines, but without increased cardiovascular or kidney event risks. The study suggests that sodium-glucose cotransporter-2 inhibitors can be safely continued in patients experiencing eGFR decline.
Researchers found that abelacimab, a Factor XI inhibitor, reduced bleeding compared to rivaroxaban in patients with atrial fibrillation. The study showed significant reduction in hospitalization due to bleeding and almost eliminated gastrointestinal bleeding.
A recent clinical trial found that semaglutide significantly reduced cardiovascular events in adults with overweight or obesity who do not have diabetes. The medication was shown to lower the risk of death from cardiovascular causes, nonfatal heart attacks, and strokes by 20% compared to placebo.
A new risk calculator estimates a person's risk for cardiovascular disease (CVD) over the next 30 years by combining measures of cardiovascular, kidney, and metabolic health. The PREVENT risk calculator uniquely quantifies risks for CVD for each biological sex, without including race as a factor.
A new study finds that people with antibodies to common foods like dairy and peanuts are at a higher risk of cardiovascular-related death. The research suggests that these subtle immune responses may lead to inflammation and contribute to heart disease over time.
A Pitt University study found that individuals with higher education levels are less likely to experience cardiovascular disease events later in life. On average, those with less than a high school education were 1.4-1.7 times more likely to have a heart attack or stroke compared to college graduates.
Researchers at the University of São Paulo have tested a synthetic molecule called AD-9308, which has shown potential in treating heart failure by activating the enzyme aldehyde dehydrogenase 2. The study found that the molecule improved mitochondrial filtration, eliminating cellular pollutants and boosting heart function by up to 40%.
A new study found that workplaces implementing flexible work arrangements can reduce employees' cardiometabolic risk, equivalent to a reduction of 5-10 years in age-related changes. The intervention had no negative impact on productivity and was particularly beneficial for low- and middle-wage workers.
A recent study in JAMA Cardiology analyzed data from 15,000 patients and found that enteric coating on aspirin does not change its effectiveness or safety for secondary prevention of cardiovascular events. The study suggests that patients can choose the aspirin formulation that suits them best.
Two new studies reveal that depression, anxiety and chronic stress increase the risk for heart and brain health complications. Researchers found that these mental health conditions can accelerate the development of cardiovascular disease risk factors.
Researchers have developed AI tools that can effectively detect heart valve disease and predict cardiovascular risk using digital stethoscopes. A study found that AI-powered digital stethoscopes predicted nearly 90% of valve disease diagnoses, offering a promising tool for transforming CVD care.
Research highlights significantly higher heart attack death rates among American Indian and Alaska Native adults, particularly at younger ages. The study suggests that factors like limited healthcare access, socioeconomic conditions, and restricted health insurance coverage may contribute to these disparities.
Yabing Chen has received two NIH grants totaling over $5 million to investigate vascular diseases and their link to dementia. Her research focuses on Runx2, a master transcription factor involved in both bone formation and calcification of arteries.
Two reproductive health conditions, polycystic ovary syndrome and dysmenorrhea, are linked to increased cardiovascular disease risk in women. Studies suggest that girls with polycystic ovary syndrome have a 30% higher risk of high blood pressure, while women with dysmenorrhea are twice as likely to experience ischemic heart disease.
A new study finds that higher cardiovascular health is associated with decelerated biological aging, as measured by phenotypic age. Greater adherence to all Life's Essential 8 metrics can slow down the body's aging process and have numerous benefits.
A recent study has found that transgender adults living in rural areas of the US are more likely to have cardiovascular disease risk factors such as tobacco use, obesity, and high blood pressure. The research highlights the need for targeted interventions to reduce health disparities among this population.
The American Heart Association has selected five finalists in its 6th annual Health Tech Competition to present their innovative technologies. The competition aims to drive technology innovation and transform the landscape of heart and brain health.
A new pathway to prevent cardiovascular disease has been discovered through a University of Minnesota-led study, highlighting the potential of TREM2 as an immunotherapeutic target. The research found that deleting the TREM2 gene in macrophages inhibited atherosclerosis progression.
A recent study analyzing global and national trends of atherosclerosis found an increasing trend in incidence from 1990 to 2019, driven by adults aged 20–54. The burden of the disease is particularly concerning in low- and middle-income countries, where it is rising significantly due to lifestyle factors and aging populations.
Greater PTSD symptoms were associated with higher carotid atherosclerosis and brain small vessel disease among midlife women. Women carrying the APOEɛ4 gene showed poorer cognitive performance in response to PTSD.
A new study from Tulane University found that frequent salt consumption is associated with a higher risk of developing Type 2 diabetes. The study surveyed over 400,000 adults and found participants who regularly added salt had a 13% to 39% increased risk of developing the disease compared to those who never or rarely used salt.
Dr. Olugbenga Ogedegbe has been recognized for his pioneering research on health disparities, chronic diseases, and cardiovascular risk reduction, particularly among Black adults in the US. His work aims to reduce hypertension control and racial inequities in cardiovascular disease outcomes.
A new wearable ECG device weighs only 10 grams and has just three 'dry' electrodes that are almost invisibly thin, capturing the heart's electrical activity with comparable precision to market devices. The device can be used for continuous monitoring and is ideal for patients in remote healthcare and ambulatory care settings.
The study analyzed global data from the past three decades, revealing an overall increase in hypertensive heart disease (HHD) prevalence but a decrease in mortality and disability-adjusted life years (DALYs). The burden of HHD is particularly concerning for healthcare systems due to higher prevalence with lower mortality rates.
A study predicts that extreme heat will lead to a 2.6-fold increase in cardiovascular-related deaths, with older and Black adults most vulnerable. The projected rise in summer days feeling at least 90 degrees could triple deaths among these populations.
A study of over 50 years found that excessive weight gain during pregnancy is associated with greater postpartum weight retention and increased risks of pregnancy complications and death. The researchers estimated associations between gestational weight gain and loss and mortality, including all-cause mortality and cardiovascular disease.
A secondary analysis of the Women's Ischemia Syndrome Evaluation (WISE) cohort study found that black and non-black women with obstructive coronary artery disease had similar long-term cardiovascular outcomes. The study suggests that guideline-based treatment, including statins and ACE inhibitors, may reduce racial disparities in cardi...
A new study published in eClinicalMedicine suggests that ECG-AI can flag some risks years sooner than current risk calculator equations by identifying signs of coronary artery disease, such as calcification and blockages. The technology has the potential to save more lives by identifying people who do not know they have coronary disease.
A new study, funded by a $3 million grant, aims to investigate whether treating insomnia can lower the risk of cardiovascular disease. The SHADES trial will recruit 200 patients and compare those who receive modernized collaborative care with standard primary care for insomnia.
A Michigan Medicine-led study reveals that older adults from distressed communities are less likely to attend cardiac rehabilitation after coronary revascularization. The study found that only 26% of patients from these areas used cardiac rehab, compared to 46% from prosperous areas.
Scientists have developed a technique to restore the function of human-derived GPCR proteins in yeast cells, which could accelerate research and lead to more effective treatments. The approach, using error-prone polymerase chain reaction, introduces random mutations that enhance protein stability and function.
A new study published in The American Journal of Clinical Nutrition found that consuming more red meat is associated with a higher risk of developing type 2 diabetes. Replacing red meat with plant-based protein sources like nuts and legumes may reduce this risk.
Researchers found that DNA damage accumulates in arteries with aging and contributes to impaired vascular function. In mice lacking or heterozygous for the double-strand DNA break repair protein ATM kinase, aging accelerated vascular dysfunction, including increased arterial stiffness and oxidative stress.
A recent study found a compelling link between vitamin B12 deficiency and chronic inflammation, which can lead to various health problems. The research revealed an inverse relationship between vitamin B12 levels and inflammatory markers in humans and mice, suggesting that higher vitamin B12 levels may lower inflammatory markers.
Researchers found that polygenic risk scores identify only 11% of individuals who develop disease and generate 5% false positives. The scores contribute little health benefit while adding cost and complexity to healthcare systems.
The Million Hearts Model significantly reduced first-time heart attacks and strokes, supporting guidelines for CVD primary prevention. The study's findings also suggest that the model can have a positive impact on Medicare spending.
A study of 42,586 low-risk patients who underwent surgical aortic valve replacement reveals a 5-year survival rate of 93%. The study used the STS National Database and found that eight-year survival was close to 90%. The results provide a benchmark for outcomes in managing aortic valve stenosis.
A new study published in the Journal of the American College of Cardiology found that stress and depression are common among women at the time of heart attack and for two months after. However, researchers discovered that women with heart attacks due to blockages had higher stress levels than those with open arteries.
Mutations in the PRDM16 gene alter heart muscle cell metabolism, leading to weakened hearts and increased risk of congenital heart failure in women. Female mice with this genetic defect experience significantly more heart problems than males.
Having obesity before and during early pregnancy is linked to adverse outcomes like high blood pressure, preeclampsia, and gestational diabetes. These complications account for a small percentage of increased cardiovascular disease risks in the years following pregnancy for people with obesity.
A new study found that pre-pregnancy obesity is a primary driver of future cardiovascular disease risk, rather than pregnancy complications. The research followed 4,216 individuals from early pregnancy to postpartum and found those with overweight or obese BMI had a higher risk of developing hypertensive disorders during pregnancy.
A study of 23,000 adults found a significant link between depressive symptoms and increased mortality from cardiovascular disease. Public health efforts can support nationwide strategies to reduce depression's burden.
A recent study found that less than one-third of TAVR patients participate in cardiac rehabilitation within 90 days after discharge. Factors such as age, frailty, and medical complexity contribute to lower enrollment rates. The study highlights the need for improved education and hospital protocols to promote post-procedure care.
A new American Heart Association advisory introduces the concept of cardiovascular-kidney-metabolic (CKM) syndrome, which affects nearly every major organ. The approach highlights the importance of screening for CKM-related conditions and addressing social factors to prevent progression.
A Singaporean study found that unvaccinated COVID-19 survivors are at a heightened risk of heart complications almost a year after recovery. The study revealed a 56% higher risk of developing new heart complications among unvaccinated survivors compared to uninfected individuals.
A post hoc analysis of 10,678 participants with atherosclerotic cardiovascular disease found no significant difference in heart attack, stroke, or death risk between enteric-coated and uncoated aspirin. Enteric-coated aspirin may offer reduced bleeding risk, but more research is needed to confirm its benefits.
A real-world study confirms the reliability and effectiveness of the Pooled Cohort Equation (PCE) in assessing cardiovascular risk, regardless of statin use. The PCE performed well across different demographics and retained accuracy with measurement factors outside its original risk profile range.
Studies show that people with metabolically healthy obesity (MHO) have a 50% increased risk of coronary heart disease, despite not exhibiting metabolic complications. This raises questions about the validity of the MHO concept.
A study published in Diabetes Care found that obesity, hypertension, and dyslipidemia alter cardiac energy production by interfering with metabolic substrate uptake. The research reveals early changes in apparently healthy middle-aged individuals, highlighting the importance of identifying mechanisms involved in heart disease onset.
Researchers identified key proteins regulating cholesterol distribution within cells, including OSBP1, ORP92, and GRAMD1s. This discovery sheds light on the critical mechanisms underlying cellular cholesterol distribution, offering insights into various health conditions.
Researchers found SARS-CoV-2 directly infects coronary arteries, causing fatty plaque to become inflamed. The virus replicates in macrophages, leading to increased inflammation and potentially worsening cardiovascular complications.
A new study has found a significant association between cannabis use disorder and an increased risk of cardiovascular disease events such as heart attacks and strokes. Adults with cannabis use disorder in Canada experienced a 60% higher risk of first-time cardiovascular disease events compared to those without the disorder.